Induction of MHC class I expression by the MHC class II transactivator CIITA

被引:186
作者
Martin, BK
Chin, KC
Olsen, JC
Skinner, CA
Dey, A
Ozato, K
Ting, JPY
机构
[1] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT IMMUNOL MICROBIOL,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,CYST FIBROSIS PULM RES & TREATMENT CTR,DEPT MED,CHAPEL HILL,NC 27599
[4] NICHHD,LAB MOL GROWTH REGULAT,NIH,BETHESDA,MD 20892
关键词
D O I
10.1016/S1074-7613(00)80347-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Major histocompatibility complex (MHC) class I-deficient cell lines were used to demonstrate that the MHC class II transactivator (CIITA) can induce surface expression of MHC class I molecules. CIITA induces the promoter of MHC class I heavy chain genes. The site alpha DNA element is the target for CIITA-induced transactivation of class I. In addition, interferon-gamma (IFN gamma)-induced MHC class I expression also requires an intact site alpha. The G3A cell line, which is defective in CIITA induction, does not induce MHC class I antigen and promoter in response to IFN gamma. Trans-dominant-negative forms of CIITA reduce class I MHC promoter function and surface antigen expression. Collectively, these data argue that CIITA has a role in class I MHC gene induction.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 50 条
  • [31] Epigenetic Regulation of the MHC Class II Transactivator CIITA in Age -Related Macular Degeneration
    Tian, Wenjian
    Dubey, Sushil Kumar
    Dubey, Rashmi
    Jung, Kyung Sik
    Kleinman, Mark Ellsworth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [32] MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
    Steidl, Christian
    Shah, Sohrab P.
    Woolcock, Bruce W.
    Rui, Lixin
    Kawahara, Masahiro
    Farinha, Pedro
    Johnson, Nathalie A.
    Zhao, Yongjun
    Telenius, Adele
    Ben Neriah, Susana
    McPherson, Andrew
    Meissner, Barbara
    Okoye, Ujunwa C.
    Diepstra, Arjan
    van den Berg, Anke
    Sun, Mark
    Leung, Gillian
    Jones, Steven J.
    Connors, Joseph M.
    Huntsman, David G.
    Savage, Kerry J.
    Rimsza, Lisa M.
    Horsman, Douglas E.
    Staudt, Louis M.
    Steidl, Ulrich
    Marra, Marco A.
    Gascoyne, Randy D.
    NATURE, 2011, 471 (7338) : 377 - +
  • [33] Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA
    Meazza, R
    Comes, A
    Barbaro, AD
    Tosi, G
    Ferrini, S
    Accolla, R
    TISSUE ANTIGENS, 2002, 59 : 5 - 5
  • [34] MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
    Christian Steidl
    Sohrab P. Shah
    Bruce W. Woolcock
    Lixin Rui
    Masahiro Kawahara
    Pedro Farinha
    Nathalie A. Johnson
    Yongjun Zhao
    Adele Telenius
    Susana Ben Neriah
    Andrew McPherson
    Barbara Meissner
    Ujunwa C. Okoye
    Arjan Diepstra
    Anke van den Berg
    Mark Sun
    Gillian Leung
    Steven J. Jones
    Joseph M. Connors
    David G. Huntsman
    Kerry J. Savage
    Lisa M. Rimsza
    Douglas E. Horsman
    Louis M. Staudt
    Ulrich Steidl
    Marco A. Marra
    Randy D. Gascoyne
    Nature, 2011, 471 : 377 - 381
  • [35] Control of tumor growth in vivo by gene therapy with the MHC class II transactivator CIITA
    Comes, A
    Meazza, R
    Tosi, G
    Barbaro, AD
    Ferrini, S
    Accolla, RS
    FASEB JOURNAL, 2000, 14 (06) : A1001 - A1001
  • [36] PML promotes MHC class II gene expression by stabilizing the class II transactivator
    Ulbricht, Tobias
    Alzrigat, Mohammad
    Horch, Almut
    Reuter, Nina
    von Mikecz, Anna
    Steimle, Viktor
    Schmitt, Eberhard
    Kraemer, Oliver H.
    Stamminger, Thomas
    Hemmerich, Peter
    JOURNAL OF CELL BIOLOGY, 2012, 199 (01) : 49 - 63
  • [37] Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
    Peijnenburg, A
    Van den Berg, R
    Van Eggermond, MJCA
    Sanal, Ö
    Vossen, JMJJ
    Lennon, AM
    Alcaïde-Loridan, C
    Van den Elsen, PJ
    IMMUNOGENETICS, 2000, 51 (01) : 42 - 49
  • [38] Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene
    A. Peijnenburg
    R. Van den Berg
    M.J.C.A. Van Eggermond
    Ö. Sanal
    J. M. J. J. Vossen
    A. -M. Lennon
    C. Alcaïde-Loridan
    P.J. Van den Elsen
    Immunogenetics, 2000, 51 : 42 - 49
  • [39] Regulation of class II MHC expression in APCs: Roles of types I, III, and IV class II transactivator
    Pai, RK
    Askew, D
    Boom, WH
    Harding, CV
    JOURNAL OF IMMUNOLOGY, 2002, 169 (03) : 1326 - 1333
  • [40] IL-27 Activates MHC Class II Expression in Intestinal Epithelial Cells via STAT1-Dependent Class II Transactivator (CIITA) Induction
    Diegelmann, Julia
    Brand, Stephan
    GASTROENTEROLOGY, 2012, 142 (05) : S865 - S865